Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults

NCT06429930 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: L608 Liposomal inhalation suspension
DRUG: Placebo Solution

Sponsor

Pharmosa Biopharm Inc.

Collaborators

[object Object]